In the current study, we investigated the effects of IL-22, a member of the IL-10 cytokine family, on human RCC cell line A498 cells in vitro and in vivo and studied the possible mechanisms underlying the anti-RCC tumor effects of the cytokine. The gene discussed is IL22; the disease is neoplasm.